Terumo To Accelerate Product Development And Expand Home Healthcare Market In Japan
This article was originally published in PharmAsia News
Executive Summary
Japanese medical device maker Terumo plans to develop new products and strengthen its home oxygen therapeutic business. The company will accelerate commercializing compact and efficient oxygen condensing devices used in home intravenous therapies. In Japan, Terumo accounts for 10 percent of the home oxygen therapeutic market and 90 percent of the home intravenous therapy market. The company is focusing in Tokyo, central Japan and the Kansai area. Patients in other areas are covered through agents or local dealers. Terumo aims to increase annual sales from an estimated ¥4.3 billion in 2009 to ¥18 billion within ten years. (Click here for more - Japanese language